Home / Actual products: Co / COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose v...
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose v...
- ID
- 39230211000001104
- Virtual product
- Generic COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials
- Name
- COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials
- Abbreviated name
- COVID-19 Vaccine Janssen 0.5ml inj multidose vials
- Description
- COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd)
- Date of name applicability
- 1 Sep 2021
- Previous Name
- COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose solution for injection multidose vials
- Supplier
- Janssen-Cilag Ltd
- Licensed as
- Medicines - MHRA/EMA
- Previously licensed as
- None
- License change reason
- Licence Granted
- Date of change of licensing authority
- 24 Nov 2021
- EMA (European Medicines Agency) Monitoring
- 1
- Restrictions on availability
- Restricted Availability
- Licensed route
- Intramuscular